Unilateral axonal or terminal injection of 6-hydroxydopamine causes rapid-onset nigrostriatal degeneration and contralateral motor impairments in the rat - PubMed (original) (raw)
Unilateral axonal or terminal injection of 6-hydroxydopamine causes rapid-onset nigrostriatal degeneration and contralateral motor impairments in the rat
Shane Grealish et al. Brain Res Bull. 2008.
Abstract
Unilateral injection of the catecholamine neurotoxin 6-hydroxydopamine into the axons or terminals of the nigrostriatal pathway is commonly used to model Parkinson's disease in experimental animals. Although the terminal lesion paradigm is considered to induce a more progressive lesion when compared to the axonal lesion, few studies have directly compared the early time-course for lesion development in these two models. Thus, this experiment sought to establish the temporal pattern of nigrostriatal degeneration and emergence of contralateral motor impairment in these models. Young adult male Lister Hooded rats were used. After baseline testing on a battery of spontaneous motor tests, standard stereotaxic techniques were used to inject 6-hydroxydopamine into the nigrostriatal axons or terminals at the level of the medial forebrain bundle or striatum respectively. From the day after lesion surgery, a subset of the rats was tested for motor performance, while another subset was used for immunohistochemical analysis. Quantitative tyrosine hydroxylase immunohistochemistry revealed that although both lesions caused a similar temporal pattern of immunopositive cell loss from the substantia nigra, the terminal lesion caused a more rapid loss of immunopositive terminals from the striatum. Despite these differences in striatal dopaminergic deafferentation, both lesion types caused a profound loss of contralateral motor function from the first day after lesion surgery. These findings illustrate the rapidity of the neuropathological and behavioural consequences of either axonal or terminal injection of 6-hydroxydopamine into the nigrostriatal pathway, and further highlight the need for a more progressive model of human Parkinson's disease.
Similar articles
- Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat.
Walsh S, Finn DP, Dowd E. Walsh S, et al. Neuroscience. 2011 Feb 23;175:251-61. doi: 10.1016/j.neuroscience.2010.12.005. Epub 2010 Dec 9. Neuroscience. 2011. PMID: 21145947 - Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease.
Decressac M, Mattsson B, Björklund A. Decressac M, et al. Exp Neurol. 2012 May;235(1):306-15. doi: 10.1016/j.expneurol.2012.02.012. Epub 2012 Feb 25. Exp Neurol. 2012. PMID: 22394547 - Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model.
Blandini F, Levandis G, Bazzini E, Nappi G, Armentero MT. Blandini F, et al. Eur J Neurosci. 2007 Jan;25(2):397-405. doi: 10.1111/j.1460-9568.2006.05285.x. Eur J Neurosci. 2007. PMID: 17284180 - The Amphetamine Induced Rotation Test: A Re-Assessment of Its Use as a Tool to Monitor Motor Impairment and Functional Recovery in Rodent Models of Parkinson's Disease.
Björklund A, Dunnett SB. Björklund A, et al. J Parkinsons Dis. 2019;9(1):17-29. doi: 10.3233/JPD-181525. J Parkinsons Dis. 2019. PMID: 30741691 Free PMC article. Review. - Behavioral analysis of motor and non-motor symptoms in rodent models of Parkinson's disease.
Dunnett SB, Lelos M. Dunnett SB, et al. Prog Brain Res. 2010;184:35-51. doi: 10.1016/S0079-6123(10)84003-8. Prog Brain Res. 2010. PMID: 20887869 Review.
Cited by
- Repeated intra-nigrostriatal injection of phorbol myristate acetate induces microglial senescence in adult rats.
Liu L, Luo XG, Yu HM, Feng Y, Ren Y, Yin YF, Shang H, He ZY. Liu L, et al. Mol Med Rep. 2015 Nov;12(5):7271-8. doi: 10.3892/mmr.2015.4412. Epub 2015 Oct 1. Mol Med Rep. 2015. PMID: 26459397 Free PMC article. - Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson's disease in the rat.
Walsh S, Mnich K, Mackie K, Gorman AM, Finn DP, Dowd E. Walsh S, et al. Brain Res Bull. 2010 Apr 5;81(6):543-8. doi: 10.1016/j.brainresbull.2010.01.009. Epub 2010 Jan 25. Brain Res Bull. 2010. PMID: 20097273 Free PMC article. - Comparison between Tail Suspension Swing Test and Standard Rotation Test in Revealing Early Motor Behavioral Changes and Neurodegeneration in 6-OHDA Hemiparkinsonian Rats.
Rosa I, Di Censo D, Ranieri B, Di Giovanni G, Scarnati E, Alecci M, Galante A, Florio TM. Rosa I, et al. Int J Mol Sci. 2020 Apr 20;21(8):2874. doi: 10.3390/ijms21082874. Int J Mol Sci. 2020. PMID: 32326015 Free PMC article. - Loss of VGLUT3 Produces Circadian-Dependent Hyperdopaminergia and Ameliorates Motor Dysfunction and l-Dopa-Mediated Dyskinesias in a Model of Parkinson's Disease.
Divito CB, Steece-Collier K, Case DT, Williams SP, Stancati JA, Zhi L, Rubio ME, Sortwell CE, Collier TJ, Sulzer D, Edwards RH, Zhang H, Seal RP. Divito CB, et al. J Neurosci. 2015 Nov 11;35(45):14983-99. doi: 10.1523/JNEUROSCI.2124-15.2015. J Neurosci. 2015. PMID: 26558771 Free PMC article. - Neurotoxic Effect of Benzo[a]pyrene and Its Possible Association with 6-Hydroxydopamine Induced Neurobehavioral Changes during Early Adolescence Period in Rats.
Das SK, Patel B, Patri M. Das SK, et al. J Toxicol. 2016;2016:8606410. doi: 10.1155/2016/8606410. Epub 2016 Feb 29. J Toxicol. 2016. PMID: 27034665 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources